STAT+: After MDMA therapy, she considered suicide. The trial data tell a different story
Critics argue that a pattern of inconsistencies in the MDMA clinical trial data and other shortcomings compromise the integrity of the studies.
The MDMA study was her last hope. She had read celebrating a 83% response rate in one small, early study of the psychedelic for treating
